Welcome to Dementias Platform UK

Detection. Treatment. Prevention.

Image showing a selection of pills and medicines

DPUK Director signs open letter calling for dementia 'medicines taskforce'

DPUK Director Professor John Gallacher has co-signed an open letter to the UK prime minister calling for greater investment in dementia research, taking inspiration from the COVID-19 vaccines effort.

A photo of the people involved in the Inspire Fund grant: Dr Sarah Bauermeister, Tim Parrynew and Feyi Raimi-Abraham, plus the ARUK and DPUK logos.

New art workshops to improve diversity in dementia research

DPUK has been awarded a £23,000 grant from Alzheimer's Research UK's Inspire Fund, which supports public engagement initiatives to improve understanding of dementia and dementia research.

A cognitive test showing numbers and coloured dots

Study in DPUK Data Portal finds recurrent depression affects cognition in over-50s

A large-scale analysis has shown that recurrent depression affects performance in several tests of thinking skills. However, this difference was not altered by taking anti-inflammatory medications.

Image of a line graph on a computer screen.

Blog post: How are rates of dementia changing?

Latest figures suggest 57 million people are living with dementia around the world. Experts are trying to predict how this number will change in the coming years to better inform global public health messaging and resource allocation.

Genetic and activity information to enhance Great Minds registry

Information available on participants in DPUK's Great Minds research volunteer registry is being enhanced with the addition of genetic information and data on members' day-to-day activity.

A box of medication spills out over a flat surface

Study finds common medications associated with dementia

A team of UK researchers has been investigating the association between prescription medications and dementia using a dataset funded by DPUK.

A group of older people smiling after exercising

Trials Delivery Framework: Q&A with Dr Vanessa Raymont

We spoke to Dr Vanessa Raymont, DPUK Associate Director, about the Trials Delivery Framework, which aims to match public volunteers with the most appropriate new dementia research studies.

Colourful stylised image of data and computer servers

DPUK joins new global data initiative to advance research in Alzheimer's

DPUK is a founding partner in the Alzheimer's Disease Data Initiative (ADDI) and its Alzheimer's disease (AD) Workbench.

About DPUK

DPUK brings together the best scientific minds and global leaders in the pharmaceutical industry to find new ways of detecting, treating and preventing dementia.

Our data-driven platform gives scientists fast access to findings, technology and volunteers – powering research to stop dementia in its tracks.

More about DPUK

Our research

Stylised image of the world featuring connecting dots

The DPUK Data Portal gives researchers rapid, secure access to millions of health research records.

More about the Data Portal

Our Trials Delivery Framework matches public volunteers to the right dementia studies.

More about the TDF

Our Experimental Medicine Incubator accelerates and de-risks the development of new treatments.

More about the EMI

Research highlights

Dr Emma Elliott and Dr Terry Quinn from the University of Glasgow team

Featured research: Could drugs that manage heart disease be used to treat dementia?

DPUK researchers at the University of Glasgow are searching for heart disease medications that may have the side-effect of treating dementia.

Featured researcher: Dr Ludovica Griffanti

DPUK grant winner Dr Ludovica Griffanti, of Oxford University's Wellcome Centre for Integrative Neuroimaging, is developing a method of synchronising brain scan measurements using large datasets.